The graduate program in Molecular Pharmacology and Physiology offers advanced training appropriate for academic and research careers in the fields of biology and medical sciences that include molecular and structural pharmacology; neuropharmacology; cellular, comparative, and organ systems physiology; translational pharmacology and neurophysiology and neuroanatomy.
Programs of study and research are developed individually in consultation with the student's adviser and advisory committee and are designed to ensure expertise in the student's principal field. Admission is ordinarily limited to applicants for the Ph.D., but admissions for a master's degree only may also be permitted.
Additional resources: All graduate student research is carried out in faculty research laboratories. In addition to all of the basic research equipment, tools, and facilities, major shared facilities include an electron microscope facility, which houses two high-resolution transmission electron microscopes and a scanning electron microscope; a professionally staffed animal-care facility fully equipped for animal maintenance, large animal surgery, and experimentation; an artificial-organ laboratory; a NMR facility with a 500 MHz (with cryogenic probe) spectrometer; a mouse transgenic and knockout core facility; a proteomics core facility including a Biacore T-100; and a molecular genetics core facility with the capacity to analyze gene-chips are available.
Ph.D.: Students must pass a preliminary research examination according to established schedules, complete and publicly defend a doctoral dissertation, and participate in the undergraduate and graduate teaching programs of the Division of Biology and Medicine. Attainment of the Ph.D. degree normally requires four to five years for Ph.D. candidates and three to four years of graduate work for M.D./Ph.D. candidates.
Admission requirements: Writing sample, in the form of a personal statement, required
GRE General: Required
GRE Subject: Recommended
Application deadline: January 7
Recruitment Day: February 1, 2013